돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1518670생성일: 2026년 10월 26일

Sodium hydride → chloro(phenyl)methyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate

https://huagongshe.com/reaction/1518670

반응식

참여 물질

역할이름HCID투입량
반응물Sodium hydrideHCID 24758—
반응물AripiprazoleHCID 60795—
반응물Chloro(phenyl)methyl carbonochloridateHCID 14320655—
용매2-MethyltetrahydrofuranHCID 7301—
용매Ethyl AcetateHCID 8857—
생성물chloro(phenyl)methyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylateHCID 66815335—

반응 단계

To a suspension of aripiprazole (1 g, 2.23 mmol) in 2-methyltetrahydrofuran (20 mL) was added NaH (178 mg, 4.46 mmol). The reaction was heated to reflux for 1.5 hours then cooled to room temperature. Chloro(phenyl)methyl carbonochloridate (1.37 g, 6.69 mmol) was then added and the reaction stirred overnight at room temperature. The reaction was cooled to 0° C., diluted with ethyl acetate (20 mL) and quenched with aqueous saturated NaHCO3 (20 mL) solution. The reaction was extracted with ethyl acetate (3×20 mL) and the combined organics washed with brine (50 mL), then dried (MgSO4) and concentrated to give chloro(phenyl)methyl 7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxylate (crude yield 2.10 g) as a 1:3 mixture of product/aripiprazole. The product was taken onto the next step crude.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US09072788B2
출처 데이터셋uspto-grants-2015_07
ORD IDord-970e7201ef9d4c48882fa491d6bdefd6
출처 메모uspto-grants-2015_07